Skip to main content
Log in

Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

In order to observe the effect of ursodeoxycholic acid (UDCA) in the treatment of intrahepatic cholestasis of pregnancy (ICP), 68 patients with ICP were equally divided into treatment group and control group at random. The patients in treatment group were administered with UDCA 300 mg three times every day and those in control group received a combination of 10% glucose, Vitamin C and Inosine. Itching scores, serum ALT and total bile acids (TBA) were measured before, during and after treatment. The results showed that as compared with those before treatment, itching scores, serum ALT and TBA were significantly reduced after treatment (P<0.05). The occurrences of premature labor, fetal asphyxia and meconium staining in amniotic fluid were significantly lower in treatment group than in control group (P<0.05). It was suggested that UDCA was an effective drug in the treatment of ICP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Palma J, Reyes H, Ribalta Jet al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology, 1992, 15(6):1043–1047

    Article  PubMed  CAS  Google Scholar 

  2. Palma J, Reyes H, Ribalta Jet al. Ursodeoxycholic acid in the treatment of cholestasis pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol, 1997, 27(6):1022–1028

    Article  PubMed  CAS  Google Scholar 

  3. Guldutuna S, Zimmer G, Imhof Met al. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology, 1993, 17:599–604

    Google Scholar 

  4. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology, 2002, 36(2):525–531

    Article  PubMed  CAS  Google Scholar 

  5. Ai Y, Liu S. Camparison of three methods in the treatment of intrahepatic cholestasis of pregrancy. J Pract Obste Gynecol, 2002, 18(1):20–22

    Google Scholar 

  6. Germain A M, Kato S, Carvajal J Aet al. Bile acids increase response and expression of humane myometrial oxytocin receptor. Am J Obstet Gynecol, 2003, 189(2):577–582

    Article  PubMed  CAS  Google Scholar 

  7. Serrano M A, Brites D, Larena M Get al. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol, 1998, 28(5):829–839

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Liu Yuling, female, born in 1973, M. D., Ph. D.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuling, L., Fuyuan, Q., Haiyi, L. et al. Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 26, 350–352 (2006). https://doi.org/10.1007/BF02829573

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02829573

Key words

Navigation